Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/201071
Type: Artigo de periódico
Title: Trimethoprim-sulfamethoxazole Versus Placebo To Reduce The Risk Of Recurrences Of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial.
Author: Felix, João Paulo Fernandes
Lira, Rodrigo Pessoa Cavalcanti
Zacchia, Rafael Santos
Toribio, Jaqueline Machado
Nascimento, Mauricio Abujamra
Arieta, Carlos Eduardo Leite
Abstract: To compare the effects of trimethoprim-sulfamethoxazole vs placebo in reducing the risk of recurrences of Toxoplasma gondii retinochoroiditis. Single-center, prospective randomized double-masked clinical trial. A total of 95 patients from Campinas, Brazil, with active recurrent Toxoplasma gondii retinochoroiditis were included. The initially active toxoplasmosis lesions were successfully treated in all cases using trimethoprim-sulfamethoxazole (800 mg/160 mg) twice daily for 45 days. Subsequently, 5 patients dropped out of the study. The remaining patients were randomized to Group 1 (trimethoprim/sulfamethoxazole tablet every 2 days) or Group 2 (identical placebo tablet every 2 days). Randomization was 1:1, was stratified by sex, and used block sizes of 4. The primary outcome was recurrent toxoplasmosis retinochoroiditis within 1 year, and the secondary outcome was a 1-year change in best-corrected visual acuity (BCVA) (ETDRS chart). The incidence of recurrent toxoplasmosis retinochoroiditis within 12 months was 0 of 46 (0%) and 6 of 47 (12.80%) in the trimethoprim-sulfamethoxazole and placebo groups, respectively (P = .026). Visual acuity improvements in the 2 groups were similar. No treatment-limiting toxicity was observed. Trimethoprim/sulfamethoxazole therapy resulted in a 100% reduction in the recurrence of Toxoplasma gondii retinochoroiditis over 1 year of treatment.
Subject: Adult
Anti-infective Agents
Chorioretinitis
Double-blind Method
Female
Follow-up Studies
Humans
Male
Prospective Studies
Secondary Prevention
Toxoplasma
Toxoplasmosis, Ocular
Trimethoprim-sulfamethoxazole Combination
Visual Acuity
Rights: fechado
Identifier DOI: 10.1016/j.ajo.2013.12.022
Address: http://www.ncbi.nlm.nih.gov/pubmed/24388839
Date Issue: 2014
Appears in Collections:Unicamp - Artigos e Outros Documentos

Files in This Item:
File SizeFormat 
pmed_24388839.pdf650.58 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.